About MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
H. Lundbeck A/S
2
Hoffmann-La Roche
2
Newron Pharmaceuticals SPA
2
ACADIA Pharmaceuticals Inc.
1
Janssen Research & Development, LLC
1
SK Life Science, Inc.
1
Sun Pharma Advanced Research Company Limited
1
Clinical Trials at MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o.
During the past decade, MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o. conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on
average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
2007-11-01
2012-03-01
Completed
679
Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa
2009-02-01
2012-03-01
Completed
549
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis
2011-09-20
2022-12-30
Completed
835
Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis
2017-09-27
2019-10-30
Completed
392
PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706
2019-02-18
2023-03-01
Recruiting
504
Cenobamate Open-Label Extension Study for YKP3089C025
2019-08-13
2023-11-01
Enrolling by invitation
130
A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments
2020-06-01
2022-09-15
Completed
892
A Study With Lu AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments
2021-11-11
2023-03-16
Completed
237
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o." #1 sponsor was "H. Lundbeck A/S" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials
sponsored, "Newron Pharmaceuticals SPA" with 2 trials sponsored, "ACADIA Pharmaceuticals Inc." with 1 trials sponsored and "Janssen Research & Development, LLC"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
Clinical Trials Conditions at MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o.
According to Clinical.Site data, the most researched conditions in "MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o." are
"Idiopathic Parkinson's Disease" (2 trials), "Migraine" (2 trials), "Dementia-related Psychosis" (1 trials), "Early Parkinson Disease" (1 trials) and "Multiple Sclerosis" (1 trials). Many other conditions were trialed in "MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o." in a lesser frequency.
Clinical Trials Intervention Types at MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o.
Most popular intervention types in "MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o." are "Drug" (10 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Ocrelizumab" (2 trials), "Cenobamate" (1 trials), "Eptinezumab" (1 trials) and "Interferon beta-1a" (1 trials). Other intervention names were less common.
Clinical Trials Genders at MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o.
The vast majority of trials in "MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o." are
10 trials for "All" genders.
Clinical Trials Status at MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o.
Currently, there are NaN active trials in "MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o.".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 6 completed trials in MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o., 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".